| Literature DB >> 11494111 |
C M Simbulan-Rosenthal1, D S Rosenthal, R B Luo, R Samara, M Jung, A Dritschilo, A Spoonde, M E Smulson.
Abstract
The tumor-suppressor p53 undergoes extensive poly(ADP-ribosyl)ation early during apoptosis in human osteosarcoma cells, and degradation of poly(ADP-ribose) (PAR) attached to p53 coincides with poly(ADP-ribose)polymerase-1, (PARP-1) cleavage, and expression of p53 target genes. The mechanism by which poly(ADP-ribosyl)ation may regulate p53 function has now been investigated. Purified wild-type PARP-1 catalyzed the poly(ADP-ribosyl) of full-length p53 in vitro. In gel supershift assays, poly(ADP-ribosyl)ation suppressed p53 binding to its DNA consensus sequence; however, when p53 remained unmodified in the presence of inactive mutant PARP-1, it retained sequence-specific DNA binding activity. Poly(ADP-ribosyl)ation of p53 by PARP-1 during early apoptosis in osteosarcoma cells also inhibited p53 interaction with its DNA consensus sequence; thus, poly(ADP-ribosyl)ation may represent a novel means for regulating transcriptional activation by p53 in vivo.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11494111 PMCID: PMC1505598 DOI: 10.1038/sj.neo.7900155
Source DB: PubMed Journal: Neoplasia ISSN: 1476-5586 Impact factor: 5.715